Title: Staff report on Sanofi's strategic use of third parties to influence the FDA
Subjects: Corrupt practices, Management, Drug approval, Anticoagulants (Medicine), Government policy, Generic drugs, Sanofi aventis (Firm), United States. Food and Drug Administration, United States
Places: United States